Ethylmalonic acid

Ethylmalonic acid is a lipid of Fatty Acyls (FA) class. Ethylmalonic acid is associated with abnormalities such as Petechiae and Metabolic Diseases. The involved functions are known as Oxidation, Catabolic Process, Excretory function and Acidemia. Ethylmalonic acid often locates in Mitochondria. The associated genes with Ethylmalonic acid are N-caproylglycine and ETHE1 gene. The related lipids are Fatty Acids and sebacic acid.

Cross Reference

Introduction

To understand associated biological information of Ethylmalonic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Ethylmalonic acid?

Ethylmalonic acid is suspected in Petechiae, Metabolic Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Ethylmalonic acid

MeSH term MeSH ID Detail
Brain Diseases D001927 27 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Intellectual Disability D008607 13 associated lipids
Metabolism, Inborn Errors D008661 46 associated lipids
Leukocytosis D007964 9 associated lipids
Lipid Metabolism, Inborn Errors D008052 26 associated lipids
Glomerulonephritis D005921 35 associated lipids
Brain Diseases, Metabolic, Inborn D020739 10 associated lipids
Vomiting D014839 21 associated lipids
Central Nervous System Diseases D002493 10 associated lipids
Brain Diseases, Metabolic D001928 9 associated lipids
Muscle Hypotonia D009123 5 associated lipids
Mitochondrial Encephalomyopathies D017237 2 associated lipids
Multiple Acyl Coenzyme A Dehydrogenase Deficiency D054069 1 associated lipids
Per page 10 20 | Total 14

PubChem Associated disorders and diseases

What pathways are associated with Ethylmalonic acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Ethylmalonic acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Ethylmalonic acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Ethylmalonic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Ethylmalonic acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Ethylmalonic acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Ethylmalonic acid?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Ethylmalonic acid

Download all related citations
Per page 10 20 50 100 | Total 119
Authors Title Published Journal PubMed Link
Liang Y et al. [Late-onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency (glutaric aciduria type II)]. 2003 Zhonghua Er Ke Za Zhi pmid:14723814
Tomlinson L et al. Cannabinoid receptor antagonist-induced striated muscle toxicity and ethylmalonic-adipic aciduria in beagle dogs. 2012 Toxicol. Sci. pmid:22821849
Takei M et al. Ethylene glycol monomethyl ether-induced toxicity is mediated through the inhibition of flavoprotein dehydrogenase enzyme family. 2010 Toxicol. Sci. pmid:20616209
Schuck PF et al. Ethylmalonic acid modulates Na+, K(+)-ATPase activity and mRNA levels in rat cerebral cortex. 2013 Synapse pmid:23161776
Zolkipli Z et al. Vulnerability to oxidative stress in vitro in pathophysiology of mitochondrial short-chain acyl-CoA dehydrogenase deficiency: response to antioxidants. 2011 PLoS ONE pmid:21483766
Skovran E et al. A systems biology approach uncovers cellular strategies used by Methylobacterium extorquens AM1 during the switch from multi- to single-carbon growth. 2010 PLoS ONE pmid:21124828
Bok LA et al. Short-chain Acyl-CoA dehydrogenase deficiency: studies in a large family adding to the complexity of the disorder. 2003 Pediatrics pmid:14595061
Corydon MJ et al. Ethylmalonic aciduria is associated with an amino acid variant of short chain acyl-coenzyme A dehydrogenase. 1996 Pediatr. Res. pmid:8725270
Gregersen N et al. C6-C10-dicarboxylic aciduria: investigations of a patient with riboflavin responsive multiple acyl-CoA dehydrogenation defects. 1982 Pediatr. Res. pmid:7145508
van Maldegem BT et al. Flavin adenine dinucleotide status and the effects of high-dose riboflavin treatment in short-chain acyl-CoA dehydrogenase deficiency. 2010 Pediatr. Res. pmid:19952864
Rinaldo P et al. Ethylmalonic/adipic aciduria: effects of oral medium-chain triglycerides, carnitine, and glycine on urinary excretion of organic acids, acylcarnitines, and acylglycines. 1991 Pediatr. Res. pmid:1945558
Wood PA et al. Short-chain acyl-coenzyme A dehydrogenase deficiency in mice. 1989 Pediatr. Res. pmid:2919115
García-Silva MT et al. Syndrome of encephalopathy, petechiae, and ethylmalonic aciduria. 1997 Pediatr. Neurol. pmid:9367300
Schimming R et al. Evaluation of microvascular bone graft reconstruction of the head and neck with 3-D 99mTc-DPD SPECT scans. 2000 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:11113810
Zannolli R et al. Silent increase of urinary ethylmalonic acid is an indicator of nonspecific brain dysfunction. 2010 NMR Biomed pmid:20187168
Plecko B Lessons to learn from rare inborn errors of metabolism. 2007 Neuropediatrics pmid:17712731
Zafeiriou DI et al. Ethylmalonic encephalopathy: clinical and biochemical observations. 2007 Neuropediatrics pmid:17712735
Westermann CM et al. Acquired multiple Acyl-CoA dehydrogenase deficiency in 10 horses with atypical myopathy. 2008 Neuromuscul. Disord. pmid:18406615
Leipnitz G et al. Ethylmalonic acid inhibits mitochondrial creatine kinase activity from cerebral cortex of young rats in vitro. 2003 Neurochem. Res. pmid:12716029
Schuck PF et al. Inhibition of creatine kinase activity in vitro by ethylmalonic acid in cerebral cortex of young rats. 2002 Neurochem. Res. pmid:12515316
Schuck PF et al. Promotion of lipid and protein oxidative damage in rat brain by ethylmalonic acid. 2010 Neurochem. Res. pmid:19757035
Srb V et al. Cytogenetic monitoring of a 24-hour effect of ethylmalonate platinum complex on human peripheral blood lymphocytes. 1986 Neoplasma pmid:3785467
Tiranti V et al. Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy. 2009 Nat. Med. pmid:19136963
Viscomi C et al. Combined treatment with oral metronidazole and N-acetylcysteine is effective in ethylmalonic encephalopathy. 2010 Nat. Med. pmid:20657580
Dusheiko G et al. Recurrent hypoglycemia associated with glutaric aciduria type II in an adult. 1979 N. Engl. J. Med. pmid:514320
Amaral AU et al. Ethylmalonic acid impairs brain mitochondrial succinate and malate transport. 2012 Mol. Genet. Metab. pmid:22133302
Westermann CM et al. Decreased oxidative phosphorylation and PGAM deficiency in horses suffering from atypical myopathy associated with acquired MADD. 2011 Mol. Genet. Metab. pmid:21843962
Di Rocco M et al. A case of ethylmalonic encephalopathy with atypical clinical and biochemical presentation. 2006 Mol. Genet. Metab. pmid:16828325
Gallant NM et al. Biochemical, molecular, and clinical characteristics of children with short chain acyl-CoA dehydrogenase deficiency detected by newborn screening in California. 2012 Mol. Genet. Metab. pmid:22424739
Nowaczyk MJ et al. Ethylmalonic and methylsuccinic aciduria in ethylmalonic encephalopathy arise from abnormal isoleucine metabolism. 1998 Metab. Clin. Exp. pmid:9667231
Barschak AG et al. Inhibition of the electron transport chain and creatine kinase activity by ethylmalonic acid in human skeletal muscle. 2006 Metab Brain Dis pmid:16773466
Ferreira Gda C et al. Effect of in vivo administration of ethylmalonic acid on energy metabolism in rat tissues. 2006 Metab Brain Dis pmid:16773468
Dweikat I et al. Ethylmalonic encephalopathy associated with crescentic glomerulonephritis. 2012 Metab Brain Dis pmid:22584649
Burlina A et al. New clinical phenotype of branched-chain acyl-CoA oxidation defect. 1991 Lancet pmid:1683940
Chae JH et al. Risk factors of ocular involvement in children with mitochondrial respiratory chain complex defect. 2010 Korean J Pediatr pmid:21253313
van Maldegem BT et al. Clinical, biochemical, and genetic heterogeneity in short-chain acyl-coenzyme A dehydrogenase deficiency. 2006 JAMA pmid:16926354
Burlina AB et al. A new syndrome with ethylmalonic aciduria and normal fatty acid oxidation in fibroblasts. 1994 J. Pediatr. pmid:8283379
Harpey JP et al. Sudden infant death syndrome and multiple acyl-coenzyme A dehydrogenase deficiency, ethylmalonic-adipic aciduria, or systemic carnitine deficiency. 1987 J. Pediatr. pmid:3585604
Grosso S et al. Ethylmalonic encephalopathy: further clinical and neuroradiological characterization. 2002 J. Neurol. pmid:12382164
Tiranti V et al. ETHE1 mutations are specific to ethylmalonic encephalopathy. 2006 J. Med. Genet. pmid:16183799
Sack I and Vega S Efficient deuterium-carbon REDOR NMR spectroscopy. 2000 J. Magn. Reson. pmid:10873496
Lehnert W and Ruitenbeek W Ethylmalonic aciduria associated with progressive neurological disease and partial cytochrome c oxidase deficiency. 1993 J. Inherit. Metab. Dis. pmid:7609451
Garavaglia B et al. Muscle cytochrome c oxidase deficiency in two Italian patients with ethylmalonic aciduria and peculiar clinical phenotype. 1994 J. Inherit. Metab. Dis. pmid:7807937
Schmidt SP et al. Toxic response caused by a misfolding variant of the mitochondrial protein short-chain acyl-CoA dehydrogenase. 2011 J. Inherit. Metab. Dis. pmid:21170680
Barth M et al. Multiple sources of metabolic disturbance in ETHE1-related ethylmalonic encephalopathy. 2010 J. Inherit. Metab. Dis. pmid:20978941
Pedersen CB et al. Antioxidant dysfunction: potential risk for neurotoxicity in ethylmalonic aciduria. 2010 J. Inherit. Metab. Dis. pmid:20443061
Merinero B et al. Persistent increase of plasma butyryl/isobutyrylcarnitine concentrations as marker of SCAD defect and ethylmalonic encephalopathy. 2006 J. Inherit. Metab. Dis. pmid:16906473
van Maldegem BT et al. Clinical aspects of short-chain acyl-CoA dehydrogenase deficiency. 2010 J. Inherit. Metab. Dis. pmid:20429031
Rodenburg RJ Biochemical diagnosis of mitochondrial disorders. 2011 J. Inherit. Metab. Dis. pmid:20440652
Bosch AM et al. Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment. 2011 J. Inherit. Metab. Dis. pmid:21110228